Seizert Capital Partners’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-105,128
| Closed | -$3.22M | – | 236 |
|
|
2016
Q2 | $3.22M | Sell |
105,128
-2,526
| -2% | -$77.3K | 0.12% | 95 |
|
|
2016
Q1 | $4.03M | Buy |
107,654
+63,519
| +144% | +$2.38M | 0.14% | 88 |
|
|
2015
Q4 | $1.91M | Sell |
44,135
-24,301
| -36% | -$1.05M | 0.06% | 137 |
|
|
2015
Q3 | $2.57M | Sell |
68,436
-103,069
| -60% | -$3.86M | 0.08% | 128 |
|
|
2015
Q2 | $5.83M | Sell |
171,505
-8,812
| -5% | -$300K | 0.15% | 89 |
|
|
2015
Q1 | $6.38M | Buy |
180,317
+23,484
| +15% | +$831K | 0.16% | 88 |
|
|
2014
Q4 | $5.34M | Buy |
156,833
+22,173
| +16% | +$755K | 0.11% | 100 |
|
|
2014
Q3 | $5.19M | Buy |
134,660
+24,335
| +22% | +$939K | 0.1% | 104 |
|
|
2014
Q2 | $4.29M | Buy |
110,325
+69,535
| +170% | +$2.71M | 0.09% | 114 |
|
|
2014
Q1 | $1.4M | Sell |
40,790
-16,200
| -28% | -$554K | 0.03% | 119 |
|
|
2013
Q4 | $1.2M | Buy |
+56,990
| New | +$1.2M | 0.03% | 123 |
|